Dirk Elston
Medical University of South Carolina
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dirk Elston as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:20 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04359823 · DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin AloneMedical University of South Carolina · completed · Actinic Porokeratosis · principal investigator
- Ph4NCT04100083 · Spironolactone for Hidradenitis SuppurativaMedical University of South Carolina · withdrawn · Hidradenitis Suppurativa · principal investigator
- Ph1NCT03953209 · Spironolactone for the Treatment of MelasmaMedical University of South Carolina · withdrawn · Melasma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:20 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.AIDS Patient Care STDS · 201257 citationsRCR 2.0
- Vertical and transverse sections of alopecia biopsy specimens: combining the two to maximize diagnostic yield.J Am Acad Dermatol · 199546 citationsRCR 2.6
- Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.JAMA Dermatol · 202242 citationsRCR 3.4
- 37 citationsRCR 8.4
- Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.Curr Med Res Opin · 200633 citationsRCR 1.1
- Treatment of port-wine stains with a short pulse width 532-nm Nd:YAG laser.J Drugs Dermatol · 201328 citationsRCR 1.8
- Randomised trial of a serious illness decision aid (Plan Well Guide) for patients and their substitute decision-makers to improve engagement in advance care planning.BMJ Support Palliat Care · 202213 citationsRCR 1.8
- Efficacy and safety of low-dose interleukin 2 in the treatment of moderate-to-severe bullous pemphigoid: A single center perspective-controlled trial.J Am Acad Dermatol · 202410 citationsRCR 1.7
- Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications.J Cutan Pathol · 20137 citationsRCR 0.3